Anti-GD2 antibody therapy alters the neuroblastoma tumor microenvironment and extends survival in TH-MYCN mice
K. O. McNerney, S. Karageorgos, G. Ferry, A. Wolpaw, C. Burudpakdee, P. Khurana, R. Vemu, A. Vu, M. D. Hogarty, H. Bassiri
bioRxiv · Jun 9, 2021 · PreprintCancer Biology